Index. English Section

Transcript

1 Index English Section Mitochondria pathogenesis and dysfunction in Alzheimer s disease. R.N.S Tasakis Social cognition in adults: the role of cognitive control. E.I. Nazlidou et al The relationships of Theory of Mind, cognitive control and memory function in Mild Cognitive Impairment: A research proposal. G. Tsentidou et al. Can the mini mental state examination detect cognitive changes in childhood and aging? E. Tsantali et al. Clinical developments in amyloid PET imaging. I. Iakovou Correlating cognitive status with electrophysiological brain networks: an exploratory study in patients with Multiple Sclerosis. V. Papaliagkas et al. Web services for Greek informal carers. A. Efthymiou et al. An e-learning tool for the paid caregivers in Greece. A. Efthymiou et al. The quick mild cognitive impairment screen: A new screening tool for mild cognitive impairment and early dementia. R. O Caoimh et al. CSF biomarkers in the early diagnosis of Alzheimer s disease. V. T. Papaliagkas Assessment of health related quality of life in elderly nursing home residents in Heraklion. A. Smyrniotaki et al. The emotional brain in the classroom. Ε. Tigka Multimodal sensing and fusion for comprehensive monitoring and feedback: the integrated Dem@Care system. A. Briassouli et al. The travails of dementia policy development in a small island state: perspectives from malta. C. Scerri Psychological and physical benefits of traditional dance programs in elderly with dementia: theoretical approaches and research results. S. Douka et al. Dyslipidemia and dementia. K. Tziomalos The effect of mental empowerment and integrative psychotherapy in patients with dementia. G. Triantafillou, T. Doskas The importance of treating dementia through art. E. Milona, T. Doskas The role of the educational games in enhancing cognitive function. M. Tourika, T. Doskas Managing caregiver s burden through group counseling and psychoeducation. G. Poulimenea, T. Doskas The effect of day center on life quality of dementia patients. A. Bolli, T. Doskas Physical therapy in patients with dementia and healthy elderly using interactive games. P. Dimitriadou Metabolomic analysis in brain research. M. I. Klapa, C.G. Vasilopoulou Neuropsychological evidence of cognitive impairment in a patient with early-onset of Parkinson's disease. E. Papahristopoulou et al. Nanoceria attenuate amyloid beta peptide- and zinc oxide nanoparticle-induced cytotoxicity in SH- SY5Y cells. K. San Tang, J. Sern Tan Primary age-related tauopathy: part or not part of Alzheimer disease? D. Kanakis The effect of Risperidone, Sertraline as monotherapy and in combination with cholinesterase inhibitors on Alzheimer Disease cognitive functioning: A randomized clinical trial. M. Melissari Tzanakaki et al. Psychological disorders of caregivers of patients with dementing disorders: Increase of psychopathology and economic crisis in Greece. I. Theotoka et al. A neuropsychological exploration of Juvenile Myoclonic Epilepsy. D. Bekiaridis-Moschou et al. Functionality in Alzheimer s disease: clinical symptoms, measures and management. M. Tsolaki, I. Lazarou Evaluation and management of speech, language, communication and eating disorders in dementias how this can improve clinical care? A short review. G. Nasios et al. Evaluation and management of speech and language disorders in Alzheimer s dementia. M. Kambanaros et al

2 Clinical presentation of dysphagia in the varied forms of dementia: A literature review. I.-E. Virvidaki et al. Neuropsychological assessment in mild cognitive impairment and Alzheimer s disease: an overview. L..Messinis et al. Arizona battery of communication disorders of dementia for evaluation of cognitive impairment in PD and early diagnosis of PDD. D. Tafiadis et al. Application of the diagnostic tool EFA-4 in dementia. S. Erkotidou et al. Cerebrospinal fluid alpha-synuclein levels in patients with Parkinson Disease, multiple system atrophy and healthy controls. G.P. Paraskevas et al. Comparing the latent structure of Raven s educational coloured progressive matrices among young children and older adults: A preliminary study. G. Papantoniou et al. Emotion decoding from dynamic visual cues in older adult stroke patients: a preliminary study. A. Sismanidi et al. Can MCI patients classified as SNAP or PART by their CSF profile be differentiated from prodromal AD patients by neuropsychological assessment? A. E. Ioannidis et al Αbstracts Foreign language learning and special educational needs: A cause for anxiety. E. Tigka Homocysteine and leukoencephalopathy. Correlation review. S. Matsoukas et al Transcranial Direct Current Stimulation (tdcs) as a cognitive enhancement therapy in Mild Cognitive Impairment and dementia. F. Sedaghat Brainbanks: How familiar are the medical students with these biobanks? I. Papagiouvanni et al. A classification and comparative study of European Biobanks. A. Arampatzis The involvement οf aging in the development of Alzheimer s disease. A. Arampatzis Measuring social cognition and cognitive control in Mild Cognitive Impairment: comparison with cognitively healthy older adults. M. Astyrakaki et al. Social cognition and cognitive control in Alzheimer s Disease: examining the differences between older adults diagnosed with MCI and AD. N. Morou et al. Attitudes and understandings of the grandchildren of dementia patients. E. Nikolaidou Use it more and keep it alive: Longitudinal cognitive training in Mild Cognitive Impairment. E.Poptsi et al Care of patient with dementia: Will or Duty. M. Eleftheriou, E. Nikolaidou Social Work in the years of economic crisis. I. Tsokanari Oral health and dementia during Economic Crisis. E. Gavopoulou Mild Cognitive Impairment and visual problems. A. Soumpourou, K. Lysitsas Mild Cognitive Impairment with behavioral problems. E. Poptsi et al Is Alzheimer's Disease type 3 diabetes? V. Papaliagkas Theory of Mind in frontotemporal dementia: Theoretical background and clinical implications. N. Morou, D. Moraitou The added value of HD-EEG recordings in the diagnosis of Alzheimer s disease and Mild cognitive impairment. Α. Tsolaki et al. Event-related potentials in the diagnosis of Alzheimer's disease and Mild Cognitive Impairment: current status and future prospects. V. Papaliagkas What do language abilities in Mild Cognitive Impairment indicate for cognitive abilities in aging? E. Tsantali et al. The present and future of functional (SPECT) imaging in dementias. G.P. Gerasimou, A. Gotzamani- Psarrakou Techniques and quantitative measurements in brain imaging with SPECT and PET. K. Badiavas A review on the diagnostic utility of EEG for the diagnosis of dementia related disorders and Mild Cognitive Impairment. K. Ntovas, M. Tsolaki Correlating cognitive status with electrophysiological brain networks: methodological aspects and preliminary results in healthy volunteers. V. Papaliagkas et al. CSF biomarkers in every day practice. G. Paraskevas et al. Theatre of the Oppressed applied to Alzheimer s caregivers. M. Toumpalidou, M. Egkiazarova Sideritis (mountain tea) and Salvia (sage) species: natural sources as potential drugs in the treatment of Alzheimer's disease. D. Lazari

3 Effects of Ginko biloba extracts on memory. Basic studies and clinical applications. N. Pitsikas Recent developments in ICT sector for people with dementia and informal caregivers in Greece. E. Margioti Alzheimer s Disease and dietary supplementation. G. C. Spatharakis Olive oil: a new source of agents against Alzheimer s disease. P. Magiatis, E. Melliou Recent findings in Alzheimer s disease and nutrition focusing on epigenetics. D. Athanasopoulos et al. Organization of mental health and psycho geriatric services. E. Zampouridou et al. Brain imaging biomarkers for early diagnosis of Alzheimer s disease: MRI, functional MRI and functional connectivity MRI. S.-H. Pelidou SPECT and PET approaches for early diagnosing dementia and MCI. F. Sedaghat Prevalence of dementia in the oldest old. U. Lucca Alzheimer s disease and subcortical vascular disease from baseline to six-year follow-up; report from the Gothenburg MCI study. A. Wallin Examination of the factors affecting subjective well-being in elders. M. Foukaki et al. Mediterranean diet and dementia: the effect of dairy consumption and red meat. E. Frouzi, A. Kafatos Caregivers of elders and dementia patients residing in care units: A comparative study examining the factors affecting their well-being. A. E. Kalaitzaki, V. Pattakou-Parassiri Financial capacity and dementia: To be or not to be an APOE e4 carrier? V. Giannouli, M. Tsolaki Amyloid encephalopathy and financial capacity: A case study. V. Giannouli, M. Tsolaki The effect of dancing in people with Parkinsonism. I. Lazarou, M. Tsolaki Overview of the Dem@Care project. I. Kompatsiaris Presentation of the Dem@Care lab and home pilot setup and testing and outcomes in Thessaloniki. M. Tsolaki et al. The use of ICT for the assessment of pre-demented and demented patients within the Dem@care project. A. König Dementia ambient care: Home-based monitoring and enablement of people with dementia. L. Hopper et al Assessment and evaluation of interventions in BPSD with the help of a multiple sensor system. C. Melander et al Cognitive impairment in multiple sclerosis. D. Haralampus The pathophysiology of cognitive dysfunction in multiple sclerosis. D. Papadopoulos Cerebral atrophy as disease progression marker in multiple sclerosis. T. Doskas Alzheimer disease co-morbidities. X. Fitsioris Amyloid beta-oligomers: a target for Alzheimer therapy? E. Giacobini A proposed protocol for cognitive training when using robot programming tasks and tangible interfaces. S. Demetriadis et al. Next steps after ASPAD. M. Tsolaki Project: Innovative Neuro-biological Assessment for mild cognitive impairment due to Alzheimer s disease and Parkinson s disease. S. Zygouris, M. Tsolaki Project: Alzheimer s disease stem-cell treatment experimental method. S.Zygouris, M. Tsolaki Exploring homeostatic value of space of institutional settings for people with dementia through an environmental analogue. K. Charras Alzheimer s disease: support for family caregivers. M.-O. Desana Diabetes and dementia. F. Iliadis Dementia Financial crisis. A. Lygera Managing Cognitive Impairment Discriminations in health. A. Τheochari Cognitive Disorders: Criticism-Present-Perspectives-Conclusions. V. Dislian Plasma metabolites as Alzheimer s Disease biomarkers. P. Proitsi et al. Forget Me Not : a constant struggle. M. Seleari Association between elderly with Mild Cognitive Impairment and Fear of Falling. C. A. Mouzakidis Categorization training for persons with Mild Cognitive Impairment. F. Constantinidou, M. Nikou Dementia caregiver burden as associated with neighbors social capital. E.Papastavrou Quality of life in healthy aging. S. Papacostas et al

4 The level of Quality of Life of dementia caregivers and its association with depression and burden: a correlation study in Cyprus. P. Andreou Impact of music intervention technique Music Care in the context of Alzheimer s disease. S. Guetin Changes in synapse in dementia: relationship to symptoms and potential therapeutic opportunities. P. Francis Adverse outcomes and delirium in demented hospitalized patients. K.G. Yiannopoulou et al. Use of assessment tools for cognitive and everyday functionality: need for separation of the healthy with the pathological spectrum in these areas of examination. G. Pavlidis Social engagement and networking as determinants of cognitive and affective well-being in the silver years. E. Chrysochoou, A. Ypsilanti Grandparenting as a protective factor against affective and cognitive decline. E. Kalyva Bilingualism as a potential factor protecting against cognitive decline. A. I. Ladas et al. Long term care for people with dementia- Facilities and approach of care. K. Prouskas Neuroimaging methods vs. lesion studies. E. Tigka The pathogenesis of dyslexia. E. Tigka Do MRI volumes correlate with financial capacity? Evidence from patients with Mild Cognitive Impairment in Greece. V. Giannouli et al. Association between helicobacter pyliri infection, glaucoma and dementia. F.Tsolaki et al. Physiopathology of the cerebral small vessel disease: the role of homocysteine. D. Dellaporta et al. Synaptic dysregulation in a patient-specific human ips-derived cellular model of Parkinson s disease. G. Kouroupi et al. Using ADVF stem cells for the treatment of Alzheimer s disease. G. Koliakos Collecting useless items. A dementia behavioral symptom or hoarding disorder? M. Egkiazarova et al. The course of caregivers in Alzheimer Disease. E. Michi Ilion municipality community study. A multi-axial approach based on the cognitive reserve theory. N. E. Degleris The introduction of a short screening test for Major Neurocognitive Disorder by laypeople. The psychometric properties of a legendary story. A. Solias et al Exploring the association between depression and major neurocognitive disorder. A. Solias et al. High correlation between frailty variables and dementia in a cohort of older people in Crete, Greece. S. Panagiotakis et al. Using novel compounds for cognitive enhancement. E.M. Tsapakis Alzheimer s Disease and dietary supplementation. G. C. Spatharakis The endocrinological facets of Alzheimer s disease and dementia-related disorders. K. A. Toulis et al. Driving ability in patients with cognitive disorders due to neurodegenerative diseases. S. G. Papageorgiou The autonomous elderly of Crete and their everyday lives: factors associated with longevity and successful aging. A. Kritikosi et al. Brain research and advocacy - a European perspective. T. Hawrot Neuropsychological tests. E. Poptsi Atypical and potentially reversible types of dementia and cognitive dysfunctions:normal pressure hydrocephalus. F. Xepapadakos et al. Limbic encephalitis a rare treatable cause of neuropsychiatric disorders. S. Friedl, F. Xepapadakos Pseudo dementia in depression and multiple myeloma with heart amyloidosis. A reversible neuroimmunologic challenge? C. Mela Reminiscence as therapeutic intervention to people with dementia. A. Diamantidou et al. Exploration of the link between depressive symptoms and driving performance in individuals with mild cognitive impairment. I. N. Beratis et al. Tandem Walking as a predictor of driving performance in individuals with Parkinson s Disease. I. N. Beratis et al. Is rapid dementia related to accelerated neuronal metabolic exhaustion? I. Ferrer Biological determinants of Alzheimer disease heterogeneity: prion paradigm implications. J.G. Safar Determinants for disease progression in AD. I. Zerr

5 Evidence for a CSF biomarker signature identifying a rapid progressive subphenotype of sporadic AD. J. Wiltfang 315 Creation of a multidimensional website thematic network for a holistic health promotion. I. Galanakis et al 315 Programs of action for dementia in the Dodecanese prefecture. T. Velegraki, K. Siaga 316 Agios Nikolaos Lasithi Memorial Centre results. E.Frouzi, Z.I. Nikolaou 316 Predicting response to cerebrospinal fluid (CSF) shunting for patients with idiopathic normal pressure hydrocephalus (inph): Reality or Utopia? F. Sotiriou 317 Alzheimer's Disease: Strategies for disease modification with an emphasis on discovering novel molecules of natural origin possessing anti-neurodegenerative properties. A. Tsarbopoulos 317 Proteplytic clearance of alpha-synuclein in vivo: Novel targets in Parkinson s disease transmission. V. Sykioti 318 Comparing the psychometric properties of the Raven s Educational Coloured Progressive Matrices among young children and older adults: A preliminary study. E. Katsadima et al 318 Comparing the psychometric properties of the ATHINA Test among young children and older adults: A preliminary study. M. Dinou et al. 319 Comparing the psychometric properties of the Children s Category Test among young children and older adults: A preliminary study. E. Foutsitzi et al. 319 Comparing the psychometric properties of the Mini-Mental State Examination among young children and older adults: A preliminary study. E. Savvidou et al. 320 Alzheimer Association of Heraklion, Crete Allilegii (Solidarity). I. Kortsidaki, I. Zaganas 320 Assistive and companion robots in the frame of the RAPP project. S. Reppou, G. Karagiannis 321 From loneliness to solitude: A journey to adulthood for dementia sufferers. A. Pagoropoulou 321 Elderly living in the Community or in Institutions, in Urban or Rural Areas Comorbidity. A. Kypraki et al. 322 Elderly living in the community or in institutions, in urban or rural areas cognitive function and Quality of Life. M.E.Mitraki et al. 322 Urban or rural areas resilience and life satisfaction. V. Pattakou-Parassiri et al 323 Prevention and management of dementia in the current financial environment. M. Karatzikou et al. 323 Suicidal attempts and depression in Mild Cognitive Impairment. A. Diamantidou 324 Case study: Everyday functioning in mild Alzheimer s disease. M. Gialaouzidis 324 Prevention and intervention in the school community to promote brain health and the pupils awareness on the problems of people suffering from Alzheimer disease. Support and education of the emotional state of caregivers and retraining of people with dementia by the carers. I. Kortsidaki et al. 325 Teaching and applications of memory strategies. A. Soumpourou 325 «Aging on action» - proposal for creative aging in the Ioannina Prefecture, region of Epirus, Greece. A. Velivasi et al. 326 NILVAD study: A European double-blind placebo-controlled phase III clinical trial of nilvadipine in patients with AD: Some preliminary findings. S. Nenopoulou et al. 326 PharmaCog study: Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a two-part clinical study. Part A. Multisite MRI acquisition Protocol harmonization. Part B. - Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a clinical study. K. Dalakouras et al. 327 Using a virtual reality cognitive training application for remote cognitive screening. S. Zygouris, M. Tsolaki 327 Physiotherapy program for the prevention of falls in patients with dementia. I. Velissaridi et al. 328 Death anxiety and religiosity in older adults. P. Damvopoulou et al. 328 Quality of sleep and working memory in old adults. I. Michos et al. 329 Evaluation with CD and cellular assays of new aggregation inhibitors of the β-amyloid peptide of Alzheimer's disease. B. Mavroidi et al. 329 The prognostic value of the number of cutan neurofibromas in neurofibromatosis. A. Horváth et al. 330 Trait and state anxiety in older adults with MCI. E. Zoupa et al 330 The effectiveness of mental empowerment program and psychotherapy on a patient with poor social network. G. Triantafillou et al. 331 The effectiveness of combined group intervention on cognitive and social skills of a patient with Alzheimer. G. Poulimenea et al. 331

6 Geriatric Anxiety Inventory. E. Poptsi et al. 332 Intervention therapy in Progressive Supranuclear Palsy. S. Kostopoulou et al. 332 Screening of dysphagia in Parkinson s Disease. G. Tegou et al. 333 Intervention program for patients with Multiple System Atrophy. Κ. Sardella et al. 333 Example of intervention plan on functional-motor level for improved functioning in everyday tasks (ADL) in patients with dementia and Parkinsonian symptoms. F. Zotou et al. 334 The role of integrative therapy on a patient with Alzheimer disease and cerebrovascular lesions (mixed type Dementia). M. Tourika et al. 334 Effects of selected biosynthetic cyclic peptides on Aβ oligomer formation and on the toxic action of Aβ oligomers in primary neurons. Z. Linardaki et al. 335 Can religiosity levels differ among cognitively intact, MCI and demented elders? Preliminary results. M. Tsatali et al. 335 The involvement of bacterial metabolites rhamnolipids in Alzheimer's disease. E.G. Andreadou et al. 336 Commentaries Items of organisation of space and behavior in it: complexity, transdisciplinarity and synthesis in memory degeneration and urban environments. M. Mitropoulos 337 Good morning, Dementia! How Alzheimer Cafe became successful in Slovenia. Š. L. Zlobec 337 Next generation sequencing technologies for whole exome/genome sequencing: impact on daily clinical practice, in dementia and beyond. Ι. Zaganas et al. 339 Greek Section English abstracts The Nocebo Phenomenon: Definition, action mechanisms, studies, ethical dilemmas and its future. Review. A.L. Gerontidis, M. Tsolaki. 341 Brainbanks: How familiar are the medical students with these biobanks? I. Papagiouvanni et al. 344 The effect of chronic stress in Alzheimer s disease. S. Karatzetzou et al. 351 Epidemiological study among deceased patients with dementia of Care at Home section and other Day Centers of the Greek Association of Alzheimer s Disease and Related Disorders. C. Papasozomenou 359 Observations relative to driving in elderly people with Alzheimer s disease. I. Katsouri et al. 364 Morphosyntactic categories of mental lexicon SLDT in Greek and their relationship with the premorbid intelligence. E. Neofytidou 375 Design principles of urban open spaces for the elderly suffering from dementia and Alzheimer. S. A. Piperidou et al. 384 Polypharmacy in the frail elderly. G. Soulis 394 Prospective Memory differences in middle-aged and older adults. I. Theodoraki et al. 398 The experience of home-based care for patients with dementia: implications for Counseling. P. Issari et al 402 Assessment of major mental disorder in urban population based on Mini Mental State Examination scale. A. Solias et al. 407 Comorbidity indicators for use in daily clinical practice of Alzheimer's disease. A comparative review. N. Malliou et al. 412 Non pharmacological interventions: enrichment cognitive strategies for brain stimulation. A. Karamberi et al. 416 New developments on the early stage of Alzheimer's disease and the synaptic functionality. M. Tsolaki et al. 424 The relationship between sense of coherence and mental health in older adults. S. Voulgaropoulou et al. 431 Neuropsychological evidence in patients with Multiple Sclerosis. E. Papachristopoulou et al. 436 Ελληνικές περιλήψεις Ο άνθρωπος ζει στον κόσμο και στον κόσμο μαθαίνει τον εαυτό του. K. Σιαμπάνη και συν. 443 Ήπια Γνωστική Διαταραχή. Εφαρμογή του διαγνωστικού εργαλείου EFA 4 σε ασθενείς με Ήπια Γνωστική Διαταραχή. Ι. Αλεξίου και συν. 449

7 Πανελλήνια Βιοτράπεζα Νευρολογικών Νοσημάτων (ΠΑ.ΒΙ.Ν.Ν.) Συναίνεση των ασθενών και των οικογενειών τους στη λήψη βιολογικών υλικών. Δ. Ανεστάκης 455 Θεατρική δραστηριότητα σε ασθενείς με Ήπια Νοητική Διαταραχή: Από την άσκηση νοητικών ικανοτήτων, στην παρουσίαση θεατρικής παράστασης. Ε. Μπακογλίδου και συν. 459 Περιλήψεις Ήπια νοητική διαταραχή και σακχαρώδης διαβήτης. Μ. Γκιόκα, Μ.Τσολάκη 462 Επίπτωση του άγχους σε ασθενείς με νόσο του Alzheimer. Δ. Ανδριόπουλος και συν. 462 Παρουσίαση βιωματικού σεμιναρίου «Ποιος είμαι εγώ, παππού;». Κ. Καραγκιόζη και συν. 463 Η άνοια μέσα από τα μάτια των παιδιών. Π. Μαργαριτίδου και συν. 463 Επίδραση του θεραπευτικού προγράμματος ασκήσεις λόγου σε ηλικιωμένους με ΗΝΔ. Μ. Βασίλογλου και συν. 464 Χαρακτηριστικά εξέλιξης ασθενών με ΗΝΔ σε άνοια. Ε. Μπακογλίδου και συν. 464 Ήπια Νοητική Διαταραχή με όγκο στο μεσολόβιο. Κ. Λυσίτσας, Ε. Μπακογλίδου 465 Σακχαρώδης διαβήτης και η σχέση του με τη Νόσο Alzheimer. Α. Μουσιώλης 465 Σακχαρώδης διαβήτης τύπου 2 και Ήπια Νοητική Διαταραχή. M. Γκιόκα και συν. 466 Απολιποπρωτεΐνη Ε και σακχαρώδης διαβήτης. Ο. Γκατζήμα και συν. 466 Κρόκος και άνοια. Ζ.Σινάκος 467 Διαταραχές μνήμης και χρήση ινδικής κάνναβης. Κ. Λυσίτσας 467 Η επίδραση του Κρόκου Κοζάνης σε ασθενείς με Ήπια Νοητική Διαταραχή. Προκαταρκτικά αποτελέσματα. Μ. Τσολάκη και συν. 468 Συσχέτιση αναισθησίας και νόσου Alzheimer. Κ. Λυσίτσας 469 Φυσικοθεραπευτική εκπαίδευση περιθαλπόντων ασθενή με άνοια. Α. Παπάντσιος 469 Ο ρόλος της άσκησης στην άνοια με νόσο του πάρκινσον. Α. Αντωνόπουλος 470 Ο ρόλος του γενικού ιατρού στην έγκαιρη διάγνωση και διαχείριση του ασθενούς και της οικογένειας με άνοια. Σ. Αργυριάδου και συν. 470 Ψυχικές διαταραχές σε άτομα με γνωσιακή έκπτωση. Ε. Κουτεντάκη 471 Εκτίμηση των γνωστικών διαταραχών και κατάλληλα εργαλεία στην Πρωτοβάθμια Φροντίδα Υγείας. Ε. Ιατράκη 471 Από την κοινότητα στο νοσοκομείο και ο ρόλος του νευρολόγου. Ι. Ζαγανάς 472 Εντυπωσιακά περιστατικά στην οδήγηση σε άτομα με Ήπια Νοητική Διαταραχή και άνοια. Ι. Κατσούρη και συν. 472 Αμοιβαία εκ περιτροπής φροντίδα ασθενών με άνοια από τους περιθάλποντες. Α. Λιάπης 473 Εργαστήριο: Διάγνωση νοητικών και λειτουργικών διαταραχών. Χ. Αγωγιάτου και συν. 473 Πτώσεις σε ηλικιωμένα άτομα, πρώιμο σύμπτωμα άνοιας. Κ. Γάτος, Γ. Γάτος 474 Κοπροφαγία, κοπρολαγνεία, «κοπρόσφαιρες» και «σοβάτισμα», σε ασθενείς με άνοια. Γ. Τσουκαλάς και συν. 474 Ζητήματα θυματοποίησης των ηλικιωμένων. Α. K. Αντωνοπούλου 475 Η απαγόρευση διακρίσεων σε βάρος των ηλικιωμένων στο πεδίο της απασχόλησης και της εργασίας. Δ. Γούλας 475 Παρατηρήσεις σε σχέση με την οδήγηση σε άτομα με Ήπια Νοητική Διαταραχή και άνοια. Ι. Κατσούρη και συν. 476 Το ελληνικό νομικό πλαίσιο δωρεάς οργάνων σώματος. Δ. Γούλας 476 Ο ρόλος της αφήγησης στον ασθενή με άνοια-alzheimer. Ε. Καμπούρα-Νιφλή και συν. 477 Δυσφαγία και άνοια: Διατηρώντας την ικανότητα σίτισης. Κ. Σδράβου 477 Η προσέγγιση Snoezelen στην άνοια. Σ.Αραμπατζή-Παρίση 478 Εργοθεραπεία και αποκατάσταση νοητικών και αντιληπτικών δεξιοτήτων ανοϊκών ασθενών με τη χρήση Η/Υ με οθόνη αφής. Φ. Ασπρίδης 478 (Νανο)Τεχνολογίες διάγνωσης και προστασίας στη νευροεκφύλιση Alzheimer. Α. Σαλίφογλου 479 Χρήση νανο-φλαβονοειδών έναντι μεταλλο-επαγόμενων νευροεκφυλιστικών διεργασιών Alzheimer. C. M. Nday και συν. 479 Alzheimer: Από τη διάγνωση περιβαλλοντικής αιτιοπαθογένεσης στην αναζήτηση περιβαλλοντικών παρεμβάσεων αντιμετώπισής της. Κ. Μ. Ζαχαρενάκης 480

8 Η δραστηριοποίηση σε ανοϊκούς ασθενείς και η εργονομική διευθέτηση του χώρου. Κ. Χ. Σταφυλαράκη 480 Το ρέον πορτραίτο της άνοιας: Η εξέλιξη της νόσου Alzheimer μέσα από την τέχνη του William Utermohlen. Ε. Γρινάκης 481 Πρωτοπαθής προοδευτική αφασία. Κ. Αυδίκου 481 Κακοποίηση στην Ήπια Νοητική Διαταραχή. Ε. Κουρουνδή 482 Αγγειακή Άνοια: Παρουσίαση περιστατικού. Χ. Ζάχου-Μεσσήνη, Ε. Κυριαζοπούλου-Ντάτσιου 482 «Άκου την ιστορία μου»: ένα ποίημα γίνεται η αφορμή για αναστοχασμό πάνω στην άνοια. Π. Μαργαριτίδου, Κ. Καραγκιόζη 483 Αριθμητική και ανάγνωση. Δ. Λιάπη και συν. 483 Θεραπευτικό πρόγραμμα ασκήσεις λόγου. Μ. Βασίλογλου και συν. 484 Ήπια νοητική διαταραχή και σακχαρώδης διαβήτης. Μ. Γκιόκα, Μ. Τσολάκη. 484 Πιλοτική μελέτη για την αποτελεσματικότητα της ομαδικής ψυχοθεραπείας και εκπαίδευσης στους περιθάλποντες των ασθενών με άνοια στο κέντρο ημέρας του Ναυτικού Νοσοκομείου Πειραιά. Ε. Μυλωνά και συν. 485 H σχέση της σωματικής άσκησης με την εργαζόμενη μνήμη και την προσοχή των ηλικιωμένων. Α.Τσουβαλά και συν. 485 Αντιοξειδωτική άμυνα και νευροπροστασία στη νευροεκφύλιση Alzheimer. Ό. Τσαβέ, Α.Σαλίφογλου 486 Μεταλλοεπαγόμενο οξειδωτικό stress και νευροπροστασία στην νευροεκφύλιση Alzheimer. Ό. Τσαβέ και συν. 486 Βελτίωση φλαβονοειδών μορφών για ανάπτυξη αντιοξειδωτικής νανοτεχνολογίας. Ε. Χαλέβας και συν. 487 Ενδιαφέροντα άρθρα σχολιασμού Ο Συνήγορος του Πολίτη και η συμβολή του για την ευημερία και αξιοπρέπεια των ατόμων με άνοια. Κ. Α. Τριανταφύλλου 488 Κυτταρικές λειτουργίες και νόσος Alzheimer. Γ.Ν. Θωμόπουλος 488 Το μάθημα ζωής του μεσήλικα, πως θα πορευθεί προς το γήρας. Κ. Γάτος 491 Παρουσίαση του Προγράμματος ΚΟΙΝ.Υ.ΣΥΣ (Κοινωνικό Υποστηρικτικό Σύστημα). Σ. Κασιδιάρης 494 Έχει παράπονο η ψυχή των νοσηλευομένων ασθενών με άνοια προς το τέλος της ζωής τους; Κ. Γάτος 496 H φυσιογνωμία ως εργαλείο στη φροντίδα των ασθενών με νόσο Alzheimer. Α. Λιάπης 499